We've gotten pretty good at spotting soft bashers

New Post Public Reply Private Reply Replies (2) Message Board
Drano
333
We've gotten pretty good at spotting soft bashers here.

For instance, posts like this, predicting doom and gloom, and then saying "but I'm not a basher" by ending with a positive note:

Quote:

Stock price will steadily decline until funding is cleared up. A deal is likely sooner or later. There is no good alternative to move forward. Leo will get it done.

Read More: https://investorshangout.com/post/view?id=537...z5jJGh5LqE



Or one like this: "I'm a real shareholder and I will buy when the stock is killed"

Quote:
Holding a bit of cash for some volatility toward the end of next week. Looking for new lows on a NR and uncertainty. Nickel shares will be a great story

Read More: https://investorshangout.com/post/view?
If I can add another 100K@0.05 great.
id=5382650#ixzz5jJHDOsO6

How can we use this information against them and get the best price? 0.06? 0.05?

Read More: https://investorshangout.com/post/view?id=538...z5jJHzxzs6

I'll take 100K at $0.06. Brass balls here are where fortunes and legendary investment stories are made.

Read More: https://investorshangout.com/post/view?id=539...z5jJKOiTrS


Then, there's the little matter of defending a basher identity that wrote something inaccurate, then said that he/she/it was referring to a different drug entirely, and that "anyone" should know magically what was meant (even though that premise was wrong too). This is just silly -- makes a person wonder why someone gets all defensive about a post that a supposedly different person wrote, that no one else understood because it was wrong.

Quote:
He was talking about the interval/frequency of the Cisplatin dosing - the only thing different about the two non-placebo B-OM arms. I think it was very clear to anyone who understands the B-OM trial.

Read More: https://investorshangout.com/post/view?id=538...z5jJII7N5X


Anyone can be wrong sometimes, but continuing to hammer an inaccurate claim made on lieHUB -- hmmmm

Quote:

The EMA is typically more stringent than the FDA. Europe in general has higher safety standards for food/drug products than the US. If we get a protocol ironed out with the EMA, it will almost certainly be good enough for the FDA.

That's why all this nonsense about Leo going to Europe because the FDA is giving him a hard time is bunk. The EMA will be the true test.

Read More: https://investorshangout.com/post/view?id=538...z5jJIyGgOh


Now that one was a masterpiece of soft-bashing. "EMA is typically more stringent" (no) -- "The EMA will be the true test" (spreading fear that the EMA won't approve, when in fact they are LESS stringent)

And speaking of masterpieces -- move along, no soft-bashing here to look at:
Quote:
My question is why $0.10-$0.14? We have been here for months. Why have they not finished us off with another hit piece. Why have they not committed another $600,000 to short another 5,000,000+ shares? They could drive this to subpenny if they wanted to.

Read More: https://investorshangout.com/post/view?id=538...z5jJJQBSEb


need I comment on this one?
Quote:
No. Only an appropriate pipeline development deal can cure what ails IPIX and have any chance of getting all shareholders into the green.

Read More: https://investorshangout.com/post/view?id=539...z5jJJtXN48


These are just from the more recent posts. I didn't feel like wasting time going back further.

Now why would anyone view this as soft-bashing?
I know why.



Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 3

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 3

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 4

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 3

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 5

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading

Top 5 Most Recently Viewed Articles

West Shore Home and Max Greyserman Unite for a Bright Future

Updated Category News Views 164

West Shore Home Welcomes PGA TOUR Star Max Greyserman West Shore Home is thrilled to announce a new partnership with Max Greyserman, a talented golfer ranked No. 36 in the world. This collaboration marks an exciting chapter for both the company and the rising PGA TOUR star, whose hard work and determination have set him apart in the professional golf arena. Building a...

Continue Reading
Discover the Future of Intelligent Care at CES 2025

Updated Category News Views 278

Join Zuowei Technology at CES 2025 to Experience Innovation Shenzhen Zuowei Technology Co., Ltd., a frontrunner in the intelligent care industry, is set to captivate audiences at CES 2025, one of the world's largest consumer electronics shows. This year’s event will be held in Las Vegas, and we invite tech enthusiasts and healthcare professionals alike to explore our...

Continue Reading
Pan Global's Exciting New Mineral Resource Estimates Unveiled

Updated Category News Views 104

Pan Global Resources Announces Maiden Mineral Resource Estimates Pan Global Resources Inc. (TSXV: PGZ, OTCQB: PGZFF) is thrilled to unveil the initial Mineral Resource Estimates (MRE) for their La Romana and Cañada Honda deposits, located within the Escacena Project. This significant development represents a pivotal achievement for Pan Global, laying the groundwork for...

Continue Reading
Mirikizumab: Eli Lilly's Breakthrough in Treating Bowel Diseases

Updated Category News Views 42

Mirikizumab's Impact on Inflammatory Bowel Diseases Eli Lilly and Company (NYSE: LLY) has recently showcased significant findings regarding its drug mirikizumab in the treatment of inflammatory bowel diseases. The results indicate that mirikizumab effectively maintains long-term remission in patients suffering from ulcerative colitis (UC) and Crohn's disease. The exciting...

Continue Reading
ZyVersa's IC 100: A Breakthrough in Stroke-Related Care

Updated Category News Views 84

Understanding Stroke and Its Aftermath Strokes impact around 795,000 individuals in the U.S. every year. One of the major risk factors contributing to strokes is obesity, with nearly one-fifth of all stroke cases linked to this condition. The consequences of a stroke can extend well beyond the initial neurological impact, as cardiac complications emerge as a notorious...

Continue Reading